Pharmaceutical Sciences Claire Jarry and Matthew S. Shive
10.2.5 Conclusion
Chitosan-based hydrogels draw their versatility from the biologi- cal and physicochemical properties associated with chitosan and chitosan derivatives. As evidenced by their varied uses from con- trolled drug delivery to tissue engineering, the physical forms of chitosan hydrogels appear to hold the most promise due mainly to their improved safety. In particular, the development of injectable and thermosensitive chitosan hydrogels has opened the door for innovative treatments using less invasive delivery methods.
References
1. Purna, S.K. and Babu, M., Collagen based dressings—a review. Burns, 26, 54, 2000.
2. Tonnesen, H.H. and Karlsen, J., Alginate in drug delivery systems. Drug. Dev. Ind. Pharm., 28, 621, 2002.
3. Price, R.D., et al., Th e role of hyaluronic acid in wound healing:
assessment of clinical evidence. Am. J. Clin. Dermatol., 6, 393, 2005.
FIGURE 10.16 Granules of BCP embedded in chitosan-GP as viewed under ESEM. Addition of BCP to chitosan-GP results in a fully inject- able solution capable of forming a solid bone graft substitute at body temperature.
4. Ishihara, M., et al., Chitosan hydrogel as a drug delivery carrier to control angiogenesis. J. Artif. Organs, 9, 8, 2006.
5. Ruel-Gariepy, E., et al., Characterization of thermosensitive chitosan gels for the sustained delivery of drugs. Int. J. Pharm., 203, 89, 2000.
6. Bernkop-Schnurch, A., Chitosan and its derivatives:
potential excipients for peroral peptide delivery systems.
Int. J. Pharm., 194, 1, 2000.
7. Gutowska, A., Jeong, B., and Jasionowski, M., Injectable gels for tissue engineering. Anat. Rec., 263, 342, 2001.
8. Felt, O., Buri, P., and Gurny, R., Chitosan: a unique polysaccha- ride for drug delivery. Drug Dev. Ind. Pharm., 24, 979, 1998.
9. Singla, A.K. and Chawla, M., Chitosan: Some pharmaceuti- cal and biological aspects–an update. J. Pharm. Pharmacol., 53, 1047, 2001.
10. Paul, W. and Sharma, C.P., Chitosan, a drug carrier for the 21st century: A review. S.T.P. Pharma. Sci., 10, 5, 2000.
11. Mattioli-Belmonte, M., Muzzarelli, B., and Muzzarelli, R.A.A., Chitin and chitosan in wound healing and other biomedical applications. Carbohydr. Eur., 19, 30, 1997.
12. Muzzarelli, R., et al., Characteristic properties of N-carboxy- butyl chitosan. Carbohydr. Polym., 11, 307, 1989.
13. Mucha, M. and Miskiewicz, D., Reactive chitosan blends for paper improvement, in Chitosan in Pharmacy and Chemistry.
Muzzarelli, R.A.A. and Muzzarelli, C., Eds., Atec, Italy, 2002, p. 251.
14. Lalov, I., et al., Treatment of waste water from distilleries wtih chitosan. Wat. Res., 34, 1503, 2000.
15. El Gaouth, A., Arul, J., and Asselin, A., Potential use of chito- san in postharvest preservation of fruits and vegetables, in Advances in Chitin and Chitosan. Brine, C.J., Sandford, P.A., and Zikakis, J.P., Eds., Elsevier Applied Science, New York, 1992, p. 440.
16. Lim, S.H. and Husdon, M., Review of chitosan and its deriva- tives as antimicrobial agents and their uses as textile chemi- cals. J. Macromol. Sci., Part C Polym. Rev., C43, 223, 2003.
17. Muzzarelli, R.A.A., Muzzarelli, C., and Terbojevich, M., Chitin chemistry, upgrading a renewable resource. Carbohydr.
Eur., 19, 10, 1997.
18. Gori, S., Gélifi cation et dégradation d’un biopolymère par voie enzymatique, in Masters of Applied Sciences in Biomedical Engineering, Montréal, École Polytechnique de Montréal, 2002.
19. Vårum, K.M., et al., In vitro degradation rates of partially N-acetylated chitosans in human serum. Carbohydr. Res., 299, 99, 1997.
20. Nordtveit, R.J., Vårum, K.M., and Smidsrød, O., Degradation of fully water-soluble, partially N-acetylated chitosans with lysozyme. Carbohyd. Polym., 23, 253, 1994.
21. Sashiwa, H., et al., Lysozyme susceptibility of partially deacetylated chitin. Int. J. Biol. Macromol., 12, 295, 1990.
22. Bernkop-Schnurch, A., Hornof, M., and Guggi, D., Th iolated chitosans. Eur. J. Pharm. Biopharm., 57, 9, 2004.
23. Gupta, P., Vermani, K., and Garg, S., Hydrogels: from con- trolled release to pH-responsive drug delivery. Drug Discov.
Today, 7, 569, 2002.
24. Argüelles-Monal, W., et al., Rheological study of the chitosan/
glutaraldehyde chemical gel system. Polym. Gels Networks, 6, 429, 1998.
25. Goycoolea, F.M., et al., Eff ect of chemical crosslinking on the swelling and shrinking properties of thermal and pH-responsive chitosan hydrogels. Macromol. Biosci., 3, 612, 2003.
26. Roberts, G.A.F. and Taylor, K.E., Chitosan gels, 3. Th e for- mation of gels by reaction of chitosan with glutaraldehyde.
Makromol. Chem., 190, 951, 1989.
27. Guo, B., Elgsaeter, A., and Stokke, B.T., Gelation kinetics of sclealdehyde–chitosan co-gels. Polym. Gels Networks, 6, 113, 1998.
28. Park, H., Park, K., and Kim, D., Preparation and swelling behavior of chitosan-based superporous hydrogels for gas- tric retention application. J. Biomed. Mater. Res. A, 76, 144, 2006.
29. Park, H. and Kim, D., Swelling and mechanical properties of glycol chitosan/poly(vinyl alcohol) IPN-type superporous hydrogels. J. Biomed. Mater. Res. A, 78A, 662, 2006.
30. Bhattarai, N., et al., PEG-graft ed chitosan as an injectable thermosensitive hydrogel for sustained protein release.
J. Control. Release, 103, 609, 2005.
31. Yeo, Y., et al., Peritoneal application of chitosan and UV-cross-linkable chitosan. J. Biomed. Mater. Res. A, 78A, 668, 2006.
32. Ono, K., et al., Photocrosslinkable chitosan as a biological adhesive. J. Biomed. Mater. Res., 49, 289, 2000.
33. Ouchi, T., Nishizawa, H., and Ohya, Y., Aggregation phe- nomenon of PEG-graft ed chitosan in aqueous solution.
Polymer, 39, 5171, 1998.
34. Felix, L., et al., Kinetics of gelation and thermal sensitivity of N-isobutyryl chitosan hydrogels. Biomacromolecules, 6, 2408, 2005.
35. Rinaudo, M., et al., Specifi c interactions in modifi ed chito- san systems. Biomacromolecules, 6, 2396, 2005.
36. Holme, K.R. and Hall, L.D., Chitosan derivatives bearing C10-alkyl glycoside branches: A temperature-induced gelling polysaccharide. Macromolecules, 24, 3828, 1991.
37. Chen, L., Tian, Z., and Du, Y., Synthesis and pH sensitivity of carboxymethyl chitosan-based polyampholyte hydro- gels for protein carrier matrices. Biomaterials, 25, 3725, 2004.
38. Valenta, C., Christen, B., and Bernkop-Schnurch, A., Chitosan–EDTA conjugate: a novel polymer for topical gels.
J. Pharm. Pharmacol., 50, 445, 1998.
39. Berger, J., et al., Structure and interactions in chitosan hydrogels formed by complexation or aggregation for bio- medical applications. Eur. J. Pharm. Biopharm., 57, 35, 2004.
40. Lin, Y.H., et al., Physically crosslinked alginate/N,O-car- boxymethyl chitosan hydrogels with calcium for oral deliv- ery of protein drugs. Biomaterials, 26, 2105, 2005.
41. Park, D.J., et al., Injectable bone using chitosan–alginate gel/
mesenchymal stem cells/BMP-2 composites. J. Cranio- maxillofac. Surg., 33, 50, 2005.
42. Marudova, M., Macdougall, A.J., and Ring, S.G., Pectin–
chitosan interactions and gel formation. Carbohydr. Res., 339, 1933, 2004.
43. Nordby, M.H., et al., Th ermoreversible gelation of aqueous mixtures of pectin and chitosan. Rheology. Biomacro- molecules, 4, 337, 2003.
44. Chellat, F., et al., In vitro and in vivo biocompatibility of chitosan–xanthan polyionic complex. J. Biomed. Mater. Res., 51, 107, 2000.
45. Tan, W., Krishnaraj, R., and Desai, T.A., Evaluation of nano- structured composite collagen–chitosan matrices for tissue engineering. Tissue Eng., 7, 203, 2001.
46. Guang Liu, W. and De Yao, K., Chitosan and its deriva- tives—a promising non-viral vector for gene transfection.
J. Control. Release, 83, 1, 2002.
47. Borchard, G., Chitosans for gene delivery. Adv. Drug Deliv.
Rev., 52, 145, 2001.
48. Ruel-Gariepy, E. and Leroux, J.C., In situ-forming hydro- gels—review of temperature-sensitive systems. Eur. J. Pharm.
Biopharm., 58, 409, 2004.
49. Bhattarai, N., Matsen, F.A., and Zhang, M., PEG-graft ed chi- tosan as an injectable thermoreversible hydrogel. Macromol.
Biosci., 5, 107, 2005.
50. Chenite, A., et al., Rheological characterisation of thermo- gelling chitosan/glycerol-phosphate solutions. Carbohydr.
Polym., 46, 39, 2001.
51. Chenite, A., et al., Novel injectable neutral solutions of chi- tosan form biodegradable gels in situ. Biomaterials, 21, 2155, 2000.
52. Kofuji, K., et al., Th e controlled release of a drug from bio- degradable chitosan gel beads. Chem. Pharm. Bull. (Tokyo), 48, 579, 2000.
53. Shu, X.Z. and Zhu, K.J., Controlled drug release properties of ionically cross-linked chitosan beads: Th e infl uence of anion structure. Int. J. Pharm., 233, 217, 2002.
54. Wang, L.Y., et al., Preparation and characterization of uni- form-sized chitosan microspheres containing insulin by membrane emulsifi cation and a two-step solidifi cation pro- cess. Colloids Surf. B Biointerfaces, 50, 126, 2006.
55. Giunchedi, P., et al., Formulation and in vivo evaluation of chlorhexidine buccal tablets prepared using drug-loaded chitosan microspheres. Eur. J. Pharm. Biopharm., 53, 233, 2002.
56. Martin, L., et al., Th e release of model macromolecules may be controlled by the hydrophobicity of palmitoyl glycol chitosan hydrogels. J. Control. Release, 80, 87, 2002.
57. Knapczyk, J., Chitosan hydrogel as a base for semisolid drug forms. Int. J. Pharm., 93, 233, 1993.
58. Lin, W.C., Yu, D.G., and Yang, M.C., pH-sensitive polyelec- trolyte complex gel microspheres composed of chitosan/
sodium tripolyphosphate/dextran sulfate: Swelling kinetics and drug delivery properties. Colloids Surf. B Biointerfaces, 44, 143, 2005.
59. Ruel-Gariepy, E., et al., A thermosensitive chitosan-based hydrogel for the local delivery of paclitaxel. Eur. J. Pharm.
Biopharm., 57, 53, 2004.
60. Muzzarelli, R.A., et al., Stimulatory eff ect on bone formation exerted by a modifi ed chitosan. Biomaterials, 15, 1075, 1994.
61. Muzzarelli, R.A., et al., Osteoconductive properties of meth- ylpyrrolidinone chitosan in an animal model. Biomaterials, 14, 925, 1993.
62. Muzzarelli, R.A., et al., Osteoconduction exerted by meth- ylpyrrolidinone chitosan used in dental surgery. Biomaterials, 14, 39, 1993.
63. Klokkevold, P.R., et al., Osteogenesis enhanced by chitosan (poly-N-acetyl glucosaminoglycan) in vitro. J. Periodontol., 67, 1170, 1996.
64. Legeros, R.Z., et al., Biphasic calcium phosphate bioceram- ics: preparation, properties and applications. J. Mater. Sci.
Mater. Med., 14, 201, 2003.
65. Daculsi, G., Biphasic calcium phosphate concept applied to artifi cial bone, implant coating and injectable bone substi- tute. Biomaterials, 19, 1473, 1998.
66. Seol, Y.J., et al., Chitosan sponges as tissue engineering scaff olds for bone formation. Biotechnol. Lett., 26, 1037, 2004.
67. Carey, L.E., et al., Premixed rapid-setting calcium phosphate composites for bone repair. Biomaterials, 26, 5002, 2005.
68. Liu, H., et al., Novel injectable calcium phosphate/chitosan composites for bone substitute materials. Acta Biomater., 2, 557, 2006.
69. Mukherjee, D.P., et al., An animal evaluation of a paste of chitosan glutamate and hydroxyapatite as a synthetic bone graft material. J. Biomed. Mater. Res. B Appl. Biomater., 67, 603, 2003.
70. Leroux, L., et al., Eff ects of various adjuvants (lactic acid, glycerol, and chitosan) on the injectability of a calcium phosphate cement. Bone, 25, 31S, 1999.
71. Jarry, C., Shive, M., and Chenite, A., An injectable biomate- rial for bone repair, material science forum, 539-543, 535, 2007.
72. Nery, E.B., et al., Tissue response to biphasic calcium phos- phate ceramic with diff erent ratios of HA/beta TCP in peri- odontal osseous defects. J. Periodontol., 63, 729, 1992.
73. Suh, J.K. and Matthew, H.W., Application of chitosan-based polysaccharide biomaterials in cartilage tissue engineering:
A review. Biomaterials, 21, 2589, 2000.
74. Hoemann, C.D., et al., Tissue engineering of cartilage using an injectable and adhesive chitosan-based cell-delivery vehicle. Osteoarthritis Cartilage, 13, 318, 2005.
75. Hoemann, C., et al., Chitosan-glycerol phosphate/blood implants elicit hyaline cartilage repair integrated with porous subchondral bone in microdrilled rabbit defects.
Osteoarthritis Cartilage, 15, 78, 2007.
76. Chevrier, A., et al., Chitosan-glycerol phosphate/blood implants increase cell recruitment, transient vascularization and subchondral bone remodeling in drilled cartilage defects. Osteoarthritis Cartilage, 15, 316, 2007.
77. Hoemann, C.D., et al., Chitosan-glycerol phosphate/blood implants improve hyaline cartilage repair in ovine microf- racture defects. J. Bone Joint Surg. Am., 87, 2671, 2005.
78. www.clinicaltrials.gov
79. Dang, J.M., et al., Temperature-responsive hydroxybutyl chitosan for the culture of mesenchymal stem cells and intervertebral disk cells. Biomaterials, 27, 406, 2006.
80. Mwale, F., et al., Biological evaluation of chitosan salts cross- linked to genipin as a cell scaff old for disk tissue engineering.
Tissue Eng., 11, 130, 2005.
81. Roughley, P., et al., Th e potential of chitosan-based gels con- taining intervertebral disc cells for nucleus pulposus supple- mentation. Biomaterials, 27, 388, 2006.
82. Muzzarelli, R.A.A., Human enzymatic activities related to the therapeutic administration of chitin derivatives. Cell.
Mol. Life Sci., 53, 131, 1997.
83. Rabea, E.I., et al., Chitosan as antimicrobial agent: Appli cations and mode of action. Biomacromolecules, 4, 1457, 2003.
84. Ishihara, M., et al., Photocrosslinkable chitosan as a dressing for wound occlusion and accelerator in healing process.
Biomaterials, 23, 833, 2002.
85. Degim, Z., et al., An investigation on skin wound healing in mice with a taurine–chitosan gel formulation. Amino Acids, 22, 187, 2002.
86. Th anou, M., Verhoef, J.C., and Junginger, H.E., Chitosan and its derivatives as intestinal absorption enhancers. Adv. Drug Deliv. Rev., 50 Suppl 1, S91, 2001.
87. Th anou, M., Verhoef, J.C., and Junginger, H.E., Oral drug absorption enhancement by chitosan and its derivatives.
Adv. Drug Deliv. Rev., 52, 117, 2001.
88. Illum, L., et al., Chitosan as a novel nasal delivery system for vaccines. Adv. Drug Deliv. Rev., 51, 81, 2001.
89. Hirano, S., Applications of chitin and chitosan in the eco- logical and environmental fi elds, in Applications of Chitin and Chitosan. Goosen, M., Eds., Lancaster, PA, 1997, p. 31.
90. Struszczyk, H. and Pospieszny, H., New applications of chitin and its derivatives in plant protection, in Applications of Chitin and Chitosan. Goosen, M., Eds., Lancaster, PA, 1997, p. 171.
91. Freepons, D., Enhancing food production with chitosan seed-coating technology, in Applications of Chitin and Chitosan. Goosen, M., Eds., Lancaster, PA, 1997, p. 129.
92. Lavertu, M., et al., High effi ciency gene transfer using chito- san/DNA nanoparticles with specifi c combinations of molecular weight and degree of deacetylation. Biomaterials, 27, 4815, 2006.
93. Sinha, V.R., et al., Chitosan microspheres as a potential car- rier for drugs. Int. J. Pharm., 274, 1, 2004.
94. Lahiji, A., et al., Chitosan supports the expression of extracellular matrix proteins in human osteoblasts and chondrocytes. J. Biomed. Mater. Res., 51, 586, 2000.
95. Bokura, H. and Kobayashi, S., Chitosan decreases total cholesterol in women: A randomized, double-blind, place- bo-controlled trial. Eur. J. Clin. Nutr., 57, 721, 2003.
96. Muzzarelli, R., Clinical and biochemical evaluation of chito- san for hypercholesterolemia and overweight control. EXS, 87, 293, 1999.
97. Takayanagi, T. and Motomizu, S., Chitosan as cationic polyelectrolyte for the modifi cation of electroosmotic fl ow and its utilization for the separation of inorganic anions by capillary zone electrophoresis. Anal. Sci., 22, 1241, 2006.
98. Jocic, D., et al., Dye sorption by wool treated with low tem- perature plasma and chitosan, in Chitosan in Pharmacy and Chemistry. Muzzarelli, R.A.A. and Muzzarelli, C., Eds., Atec, Italy, 2002, p. 317.
99. Bumgardner, J.D., et al., Chitosan: potential use as a bioac- tive coating for orthopaedic and craniofacial/dental implants. J. Biomater. Sci. Polym. Ed., 14, 423, 2003.
100. Lang, G., Wendel, H., and Konrad, E., Quaternary hydroxy- ethyl-substituted chitosan derivatives, cosmetic composi- tions based thereon and processes for the production thereof, Patent, US4772690, 1988.
101. Wedmore, I., et al., A special report on the chitosan-based hemostatic dressing: Experience in current combat opera- tions. J. Trauma., 60, 655, 2006.
102. Lee, K.Y., Ha, W.S., and Park, W.H., Blood compatibility and biodegradability of partially N-acylated chitosan deriva- tives. Biomaterials, 16, 1211, 1995.
103. Rao, S.B. and Sharma, C.P., Use of chitosan as a biomaterial:
studies on its safety and hemostatic potential. J. Biomed.
Mater. Res., 34, 21, 1997.
104. Kawakami, T., et al., Experimental study on osteoconductive properties of a chitosan-bonded hydroxyapatite self-hard- ening paste. Biomaterials, 13, 759, 1992.
105. Ueno, H., Mori, T., and Fujinaga, T., Topical formulations and wound healing applications of chitosan. Adv. Drug Deliv. Rev., 52, 105, 2001.
106. Muzzarelli, R., et al., Biochemistry, histology and clinical uses of chitins and chitosans in wound healing. EXS, 87, 251, 1999.